Acro Biomedical Co., Ltd. (ACBM)
Acro Biomedical Co., Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Fishers, IN, US. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $1.6M. On trailing twelve-month figures it carries a trailing P/E of -11.30, a net margin of 0.0%. Its beta of -2.31 implies it has historically moved less than the broad market.
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
Acro Biomedical Co., Ltd. is most often compared with the following Healthcare names: